This study addresses the challenges of aberrant pre-mRNA splicing in Pompe disease, caused by pathogenic variants in the acid α-glucosidase (GAA) gene. These variants often lead to the use of cryptic splice sites, resulting in disrupted protein production. The research proposes a pipeline to identify these splicing defects and correct them using antisense oligonucleotides (AONs).   The team developed a splicing assay to detect aberrant splicing patterns in patient-derived fibroblasts. …

more